These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8769777
41. VEGF-induced permeability increase is mediated by caveolae. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, Caldwell RB. Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439 [Abstract] [Full Text] [Related]
43. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. Weihrauch D, Tessmer J, Warltier DC, Chilian WM. Am J Physiol; 1998 Sep; 275(3):H969-76. PubMed ID: 9724302 [Abstract] [Full Text] [Related]
44. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells. Chen JH, Wang XC, Kan M, Sato JD. Cell Biol Int; 2001 Sep; 25(3):257-60. PubMed ID: 11352499 [Abstract] [Full Text] [Related]
46. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Tilton RG, Chang KC, LeJeune WS, Stephan CC, Brock TA, Williamson JR. Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972 [Abstract] [Full Text] [Related]
48. Role of nitric oxide in the angiogenesis of avascular tissue. Ziche M. Osteoarthritis Cartilage; 1999 Jul; 7(4):403-5. PubMed ID: 10419781 [Abstract] [Full Text] [Related]
49. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo. Kranz A, Mayr U, Frank H, Waltenberger J. Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036 [Abstract] [Full Text] [Related]
50. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Landgren E, Schiller P, Cao Y, Claesson-Welsh L. Oncogene; 1998 Jan 22; 16(3):359-67. PubMed ID: 9467961 [Abstract] [Full Text] [Related]
51. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells. Cha MS, Lee MJ, Je GH, Kwak JY. Biochem Biophys Res Commun; 2001 Apr 13; 282(4):1061-6. PubMed ID: 11352660 [Abstract] [Full Text] [Related]
52. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Tofukuji M, Metais C, Li J, Franklin A, Simons M, Sellke FW. Circulation; 1998 Nov 10; 98(19 Suppl):II242-6; discussion II247-8. PubMed ID: 9852909 [Abstract] [Full Text] [Related]
56. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Sirois MG, Edelman ER. Am J Physiol; 1997 Jun 10; 272(6 Pt 2):H2746-56. PubMed ID: 9227554 [Abstract] [Full Text] [Related]
57. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Zhang Y, Li J, Partovian C, Sellke FW, Simons M. Am J Physiol Heart Circ Physiol; 2003 Jun 10; 284(6):H2078-82. PubMed ID: 12543640 [Abstract] [Full Text] [Related]
58. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. Heba G, Krzemiński T, Porc M, Grzyb J, Ratajska A, Dembińska-Kieć A. J Vasc Res; 2001 Jun 10; 38(3):288-300. PubMed ID: 11399901 [Abstract] [Full Text] [Related]
59. The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules. Wu MH, Yuan SY, Granger HJ. J Physiol; 2005 Feb 15; 563(Pt 1):95-104. PubMed ID: 15539400 [Abstract] [Full Text] [Related]
60. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Lal BK, Varma S, Pappas PJ, Hobson RW, Durán WN. Microvasc Res; 2001 Nov 15; 62(3):252-62. PubMed ID: 11678628 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]